Trials / Unknown
UnknownNCT05057832
Determination of Ustekinumab Levels in Patients With Crohn's Disease
Determination of Ustekinumab Levels in Patients With Crohn's Disease: Use in Clinical Practice
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 95 (estimated)
- Sponsor
- Fundación Pública Andaluza para la gestión de la Investigación en Sevilla · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Observational, prospective, single-center follow-up study carried out with patients from the area of the Virgen de Macarena University Hospital, diagnosed with chronic kidney disease, who started treatment with ustekinumab.
Detailed description
Prospective follow-up observational study carried out with patients from the Virgen de Macarena University Hospital, under treatment with ustekinumab in the induction and maintenance phase in order to determine the cut-off points of the ustekinumab levels between which a clinical remission is expected in patients with inflammatory bowel disease.
Conditions
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2022-02-01
- Completion
- 2022-02-01
- First posted
- 2021-09-27
- Last updated
- 2021-11-17
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05057832. Inclusion in this directory is not an endorsement.